Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Other Gross PP&E Adjustments (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Other Gross PP&E Adjustments data on record, last reported at -$2.5 million in Q3 2022.

  • For Q3 2022, Other Gross PP&E Adjustments fell 1012.78% year-over-year to -$2.5 million; the TTM value through Sep 2022 reached -$2.5 million, down 1012.78%, while the annual FY2021 figure was -$5.6 million, 530.04% down from the prior year.
  • Other Gross PP&E Adjustments reached -$2.5 million in Q3 2022 per AVIR's latest filing, up from -$2.7 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $175000.0 in Q3 2020 and bottomed at -$5.6 million in Q4 2021.
  • Average Other Gross PP&E Adjustments over 3 years is -$1.7 million, with a median of -$892000.0 recorded in 2020.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 229.71% in 2021, then tumbled 1012.78% in 2022.
  • A 3-year view of Other Gross PP&E Adjustments shows it stood at -$892000.0 in 2020, then tumbled by 530.04% to -$5.6 million in 2021, then surged by 55.05% to -$2.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$2.5 million in Q3 2022, -$2.7 million in Q2 2022, and -$2.9 million in Q1 2022.